Vasculitis & polymyalgia rheumatica
Medication adherence in Behçet’s syndrome: real-world data from a tertiary referral cohort
Authors' conclusion
Medication adherence in BS appeared generally satisfactory, although a relevant proportion of patients reported suboptimal adherence. These findings confirm, in a BS-specific real-world setting, previously reported associations between age and medication adherence observed in chronic diseases.
Study context
- Population
- Patients with Behçet's syndrome (BS) followed at a tertiary referral centre
- Participants
- 125 patients
- Outcome
- Medication adherence (MMAS-8): high (score=8), intermediate (score 6-<8), low (score<6)
Methodological detailsmonocentric, tertiary referral centre
- Monocentric
- Tertiary referral centre
Main finding
As reported in the abstract
Medication adherence (MMAS-8)
Mean Morisky Medication Adherence Scale (MMAS-8) score
6.82±1.32
High adherence
29.6%
Intermediate adherence
48.8%
Low adherence
21.6%
Observational data: associations, not effects.
Further findings
Factors associated with reduced adherence
- Lower adherence more frequent in lower age quartiles
- No significant associations between adherence and sex, disease duration, disease activity indices or treatment class
Original publication
Medication adherence in Behçet’s syndrome: real-world data from a tertiary referral cohort. RMD Open. Published 20 July 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →